Mechanistic insights into the superior clinical efficacy of prasugrel over ticagrelor.
作者信息
Schüpke Stefanie, Kastrati Adnan
机构信息
ISAResearch Center, Deutsches Herzzentrum München, Technische Universität, Munich, Germany.
DZHK, Partner Site Munich Heart Alliance, Munich, Germany.
出版信息
Eur Heart J. 2020 Sep 1;41(33):3153-3155. doi: 10.1093/eurheartj/ehz938.
PMID:31930293
Abstract
摘要
相似文献
1
Mechanistic insights into the superior clinical efficacy of prasugrel over ticagrelor.
Eur Heart J. 2020 Sep 1;41(33):3153-3155. doi: 10.1093/eurheartj/ehz938.
2
Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study.替格瑞洛、普拉格雷或氯吡格雷对血管内皮功能和其他血管生物标志物的影响：一项随机交叉研究。
JACC Cardiovasc Interv. 2018 Aug 27;11(16):1576-1586. doi: 10.1016/j.jcin.2018.04.022. Epub 2018 May 24.
3
Prasugrel and Ticagrelor: the Romulus and Remus of Antiplatelet Therapy?普拉格雷和替格瑞洛：抗血小板治疗中的罗慕路斯和雷穆斯？
Am J Cardiovasc Drugs. 2019 Aug;19(4):377-379. doi: 10.1007/s40256-019-00340-w.
4
[The ISAR-REACT 5 trial: is there a winner between prasugrel and ticagrelor in acute coronary syndromes?].[ISAR-REACT 5试验：在急性冠状动脉综合征中，普拉格雷和替格瑞洛谁更胜一筹？]
G Ital Cardiol (Rome). 2020 Mar;21(3):171-174. doi: 10.1714/3306.32764.
5
Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome.急性冠脉综合征患者血小板不成熟对替格瑞洛和普拉格雷血小板反应的影响。
Eur Heart J. 2015 Dec 1;36(45):3202-10. doi: 10.1093/eurheartj/ehv326. Epub 2015 Jul 27.
6
Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified?在非ST段抬高型急性冠状动脉综合征中，普拉格雷优于替格瑞洛：这合理吗？
Eur Heart J. 2021 Jul 8;42(26):2609-2610. doi: 10.1093/eurheartj/ehaa880.
7
Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified?
Eur Heart J. 2021 Jul 8;42(26):2611-2612. doi: 10.1093/eurheartj/ehaa883.
8
Comparison of platelet reactivity between prasugrel and ticagrelor in patients with acute coronary syndrome: a meta-analysis.比较急性冠状动脉综合征患者中普拉格雷和替格瑞洛的血小板反应性：一项荟萃分析。
BMC Cardiovasc Disord. 2020 Oct 1;20(1):430. doi: 10.1186/s12872-020-01603-0.
9
Newer antiplatelet agents in acute coronary syndrome.急性冠状动脉综合征中的新型抗血小板药物。
BMJ. 2016 Jan 7;352:h7025. doi: 10.1136/bmj.h7025.
10
Real-World Comparison of Clopidogrel With Ticagrelor and Prasugrel in Patients With Chronic Coronary Disease Who Underwent Atherectomy.氯吡格雷与替格瑞洛和普拉格雷在接受血管成形术的慢性冠状动脉疾病患者中的真实世界比较。
Am J Cardiol. 2024 Apr 15;217:1-4. doi: 10.1016/j.amjcard.2024.02.006. Epub 2024 Feb 23.
Zotero 插件